Directory
>
Paula Soteropoulos
Paula Soteropoulos
Venture Partner | Ensoma
Boston, Massachusetts, United States
Paula Soteropoulos
Summary
Paula Soteropoulos is a seasoned biotech executive leader and venture investor with over 35 years of experience in the biopharmaceutical industry. She has a proven track record of founding and leading companies, including Akcea Therapeutics, where she served as the founding CEO and led the company through its IPO. Paula's extensive expertise spans drug development, global commercialization, and operational leadership across various therapeutic areas, particularly in rare diseases. Her leadership roles on multiple boards reflect her influence in the industry, focusing on innovative medicines and patient-centered approaches. Paula's strategic vision and commitment to advancing healthcare are evident in her work with emerging biotech firms. She is passionate about fostering new ventures that deliver groundbreaking treatments to patients in need.
Paula Soteropoulos
Work Experience
Venture Partner at
5AM Ventures
January 2023 - Present
Board of Directors at
Dianthus Therapeutics, Inc.
May 2022 - Present
Chairman of the Board at
Ensoma
October 2021 - Present
Board of Directors at
Kyowa Kirin, Inc.- U.S.
September 2021 - Present
Strategic Advisory Board at
Chiesi USA, Inc.
February 2021 - Present
Board of Directors at
Rallybio
November 2020 - Present
Advisory Board, Department of Chemical and Biochemical Engineering at
Tufts University
January 2005 - Present
Corporate Board of Directors at
uniQure
June 2013 - June 2024
Interim CEO and Chairman of the Board at
Ensoma
January 2024 - May 2024
Venture Advisor at
5AM Ventures
March 2020 - January 2023
Founding Executive Chairman at
Ensoma
March 2020 - October 2021
Founding CEO at
Ionis Pharmaceuticals, Inc.
January 2015 - September 2019
Senior Vice President and General Manager, Cardiometabolic, Rare Diseases and Strategic Alliances at
Moderna, Inc.
July 2013 - December 2014
Vice President & General Manager, Cardiovascular at
Sanofi
October 2009 - March 2013
VP & Product General Manager, Transplant/Oncology at
Sanofi
August 2008 - October 2009
Vice President, Global Strategic Marketing, Transplant at
Sanofi
August 2007 - August 2008
Vice President, Tolevamer Commercial Operations at
Sanofi
January 2006 - August 2007
VP, Program Management & Strategic Development at
Sanofi
January 2003 - January 2006
Senior Director, Renagel Operations, Genzyme Renal at
Sanofi
January 2000 - January 2003
Director Capital Project Management, Genzyme Global Operations at
Sanofi
January 1998 - January 2000
Engineering Management (various positions) at
Sanofi
January 1992 - January 1998
Project Engineer/Process Engineer at
Badger Engineers Raytheon
May 1991 - August 1992
Project Engineer/Process Engineer at
Carlson Process
January 1989 - January 1991
Cell culture at
Integrated Genetics
January 1988 - January 1989
Paula Soteropoulos
Education
Darden Graduate School of Business Administration, Executive General Management Certificate Program
Tufts University, Master's And Bachelor's
Frequently Asked Questions about Paula Soteropoulos
What is Paula Soteropoulos email address?
Paula Soteropoulos's primary email address is *****@5amventures.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paula Soteropoulos work for?
Paula Soteropoulos is a Venture Partner at Ensoma, a company specializing in Commercial physical research.
Where Paula Soteropoulos graduated from?
Paula Soteropoulos holds a degree in Business Administration And General Management from Darden Graduate School of Business Administration.
How can I directly contact Paula Soteropoulos?
To contact Paula Soteropoulos directly, you can use the email address *****@5amventures.com. Complete contact information is available upon registration with Muraena.
Who is Paula Soteropoulos?
Paula Soteropoulos is a seasoned biotech executive leader and venture investor with over 35 years of experience in the biopharmaceutical industry. She has a proven track record of founding and leading companies, including Akcea Therapeutics, where she served as the founding CEO and led the company through its IPO. Paula's extensive expertise spans drug development, global commercialization, and operational leadership across various therapeutic areas, particularly in rare diseases. Her leadership roles on multiple boards reflect her influence in the industry, focusing on innovative medicines and patient-centered approaches. Paula's strategic vision and commitment to advancing healthcare are evident in her work with emerging biotech firms. She is passionate about fostering new ventures that deliver groundbreaking treatments to patients in need.
Paula`s contact details
*****@5amventures.com
*************@ensoma.com
******************@tufts.edu
*************@rallybio.com
*************@akceatx.com
******************@genzyme.com
Colleagues
Vice President, Translational Research and Early Development
Vice President, Gene editing
Senior Vice President, People and Culture
Vice President, Platform Technologies
Vice President, Program and Alliance Management
Chief Technology Officer
Senior Vice President, Legal and Intellectual Property
Vice President, Process and Analytical Development
Vice President Finance